HER2 Amplified
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Study to Assess the Efficacy and Safety of Enzalutamide With Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2 Positive (HER2+), Androgen Receptor Positive (AR+) Metastatic or Locally Advanced Breast Cancer (NCT02091960) | Astellas Pharma Global Development, Inc. | 2014-09-05 |
Track HER2 Amplified automatically
Every clearance here is in the API, with alerts when new ones post.